Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura

Haematologica

Volumn 81, Issue 1, 1996, Pages 3-7

  Vianelli, Nicola ^a,b   Catani, Lucia ^a   Gugliotta, Luigi ^a   Nocentini, Franco ^a   Baravelli, Stefano ^a   Lancellotti, Giustina ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

P selectin; Thrombomodulin; Thrombotic thrombocytopenic purpura

Indexed keywords

PADGEM PROTEIN; PREDNISONE; THROMBOMODULIN; TICLOPIDINE; VINCRISTINE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; PLASMAPHERESIS; REMISSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION;

EID: 0030326825     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hau CK. Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24:71-81.
2. Bukowsky RM. Thrombotic thrombocytopenic purpura: a review. Prog Hemost Thromb 1982; 6:287-337.
3. Murphy WG, Moore JC, Kelton JG. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood 1987; 70:1683-7.
4. Falanga A, Consonni R, Ruggenenti P, Barbui T. A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura. Br J Haematol 1991; 79:474-80.
5. Kelton JG, Moore JC, Murphy WG. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura. Blood 1987; 69: 924-8.
6. Moake JL, Mc Pherson PD. Von Willebrand factor in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. Transfusion Med Rev 1990; 4:163-6.
7. Moore JC, Murphy WG, Kelton JG. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 1990; 74:457-64.
8. Ruggenenti P, Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 1990; 4:219-41.
9. Bukowski RM, Hewlett JS, Reimer RR, Groppe CW, Weick JK, Livingston RB. Therapy of thrombotic thrombocytopenic purpura: an overview. Semin Thromb Hemost 1981; 7: 1-8.
10. Centurioni R, Bobbio Pallavicini E, Porta C, et al. Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Haematologica 1995; 80:325-31.
11. Bobbio Pallavicini F., Porta C, Tacconi F, et al. Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Haematologica 1995; 80:429-37.
12. Ishii H, Mayerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76:2178-81.
13. Hoffman M, Monroe DM, Roberts HR. Platelet activation in patients with thrombotic thrombocytopenic purpura. Am J Hematol 1993; 42:182-5.
14. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-Selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83:1535-41.
15. Katayama M, Handa M, Araki Y, et al. Soluble P-Selectin is present in normal circulation and its plasma level is elevated in patients with thombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 1993; 84:702-10.
16. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfuction: does it exist? Br J Haematol 1995; 90: 244-8.
17. Catani L, Gugliotta L, Vianelli N, et al. Endothelium and bone marrow transplantation Bone Marrow Transplant 1995 (in press).
18. Wada H, Ohiwa M, Kaneko T, et al. Plasma Thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 1992; 39:20-4.
19. Zauli G, Catani L, Gugliotta L, Vianelli N, Mattioli Belmonte M, Tura S. Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis. Br J Haematol 1993; 84: 381-6.